Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Clinical trial NCT05116813 · TERMINATED

Trial details

NCT number: NCT05116813
Sponsor: Addex Pharma S.A.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Disease Dyskinesia, Drug-Induced Dyskinesias

Start date: 2021-10-25
Primary completion: 2022-06-17
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.